Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
Authors
Keywords
-
Journal
Cancer & Metabolism
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-24
DOI
10.1186/s40170-021-00270-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
- (2021) Carl M. Gay et al. CANCER CELL
- ROS in cancer therapy: the bright side of the moon
- (2020) Bruno Perillo et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate
- (2020) Abbie S. Ireland et al. CANCER CELL
- Proline Metabolism in Tumor Growth and Metastatic Progression
- (2020) Cristina D'Aniello et al. Frontiers in Oncology
- Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
- (2020) Fang Huang et al. JOURNAL OF CLINICAL INVESTIGATION
- The quantitative relationship between isotopic and net contributions of lactate and glucose to the TCA cycle
- (2019) Minfeng Ying et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The landscape of cancer cell line metabolism
- (2019) Haoxin Li et al. NATURE MEDICINE
- MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion
- (2019) Milind D. Chalishazar et al. CLINICAL CANCER RESEARCH
- Targeting metabolism to regulate immune responses in autoimmunity and cancer
- (2019) Chirag H. Patel et al. NATURE REVIEWS DRUG DISCOVERY
- MYC Expression and Metabolic Redox Changes in Cancer Cells: A Synergy Able to Induce Chemoresistance
- (2019) Barbara Marengo et al. Oxidative Medicine and Cellular Longevity
- Exploiting metabolic vulnerabilities of Non small cell lung carcinoma
- (2019) Blanca Majem et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
- (2019) Pei-Hsuan Chen et al. MOLECULAR CELL
- PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses
- (2019) Sayantani Sarkar Bhattacharya et al. Cell Death & Disease
- Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses
- (2019) Taofeek K. Owonikoko et al. Journal of Thoracic Oncology
- Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers
- (2018) Fang Huang et al. Cell Metabolism
- The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues
- (2018) Eric S. Goetzman et al. Frontiers in Endocrinology
- Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
- (2018) Susmita Mondal et al. INTERNATIONAL JOURNAL OF CANCER
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Influence of Metabolism on Drug Response in Cancer
- (2018) Esther A. Zaal et al. Frontiers in Oncology
- Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation
- (2017) Ian A. Bettencourt et al. JOURNAL OF IMMUNOLOGY
- Metformin partially reverses the carboplatin-resistance in NSCLC by inhibiting glucose metabolism
- (2017) Yong Liu et al. Oncotarget
- Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies
- (2017) Robert J. Cardnell et al. Oncotarget
- Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
- (2017) Medhi Wangpaichitr et al. Oncotarget
- Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
- (2017) Kentaro Inamura Frontiers in Oncology
- Carnitine transport and fatty acid oxidation
- (2016) Nicola Longo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Metabolic Heterogeneity in Human Lung Tumors
- (2016) Christopher T. Hensley et al. CELL
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
- (2016) Roman Camarda et al. NATURE MEDICINE
- Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer
- (2016) Robert J. Cardnell et al. PLoS One
- drexplorer: A tool to explore dose–response relationships and drug–drug interactions
- (2015) Pan Tong et al. BIOINFORMATICS
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Comprehensive genomic profiles of small cell lung cancer
- (2015) Julie George et al. NATURE
- Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy
- (2015) Xue-bing Li et al. Thoracic Cancer
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
- (2013) Elizabeth J. Sullivan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- PRC2 overexpression and PRC2-target gene repression relating to poorer prognosis in small cell lung cancer
- (2013) Teruyuki Sato et al. Scientific Reports
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- c-Myc and Cancer Metabolism
- (2012) D. M. Miller et al. CLINICAL CANCER RESEARCH
- Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
- (2012) Martin Peifer et al. NATURE GENETICS
- Characterization of the cell of origin for small cell lung cancer
- (2011) Kwon-Sik Park et al. CELL CYCLE
- Reactive oxygen species in cancer
- (2010) Geou-Yarh Liou et al. FREE RADICAL RESEARCH
- Cancer as a metabolic disease
- (2010) Thomas N Seyfried et al. Nutrition & Metabolism
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Pyruvate into lactate and back: From the Warburg effect to symbiotic energy fuel exchange in cancer cells
- (2009) Olivier Feron RADIOTHERAPY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started